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Abstract 
Clostridium difficile is recognized as a major cause of nosocomial acquired antibiotic-associated diarrhea and pseu-
domembranous colitis. It is a significant financial burden on modern healthcare resources. This study aimed to assess 
the molecular characterization of C. difficile strains isolated from children under 5 years old suffered from nosocomial 
diarrhea. One hundred diarrheic and 130 non-diarrheic fecal samples were collected from pediatrics less than 5 years 
old. Samples were cultured and C. difficile isolates were subjected to the PCR technique to study the distribution of 
ribotypes of C. difficile using P3 and P5 primers. Fifty-two out of 100 samples (52 %) were positive for C. difficile. The 
prevalence of bacterium in healthy children was 4.61 %. Total prevalence of C. difficile in diarrheic girls and boys were 
48.9 and 54.7 %, respectively. Thirteen to twenty-four month age children had the highest prevalence of C. difficile. The 
most commonly detected ribotypes in the C. difficile isolates of Iranian pediatrics were RT027 (11.52 %), R1 (9.61 %) 
and R13 (7.68 %). The ribotypes of all of the six bacterial isolates of healthy children was not diagnosed. According to 
the presence of C. difficile and R27 ribotype, a continued genotype surveillance of this bacterium is necessary to moni-
tor changes in the prevalence of certain strains and to identify the emergence of new strains that could affect future 
vaccine strategies.
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Background
Diarrhea is one of the most common diseases in chil-
dren in developed and developing countries. It has been 
documented that there are about two billion cases of 
diarrheal disease worldwide every year and 1.9 million 
children younger than 5 years of age hospitalized due to 
diarrhea each year (Farthing et al. 2013). It has also been 
recorded that more than 5000 children are dying every 
day as a result of diarrheal diseases (Farthing et al. 2013). 
One of the most prevalent cause of diarrhea in children 
less than 5  years old is Clostridium difficile (C. difficile) 
(Wilson 2006; Koletzko and Osterrieder 2009). C. difficile 
is a spore-forming, anaerobic, gram-positive bacillus an 
etiologic agent of nosocomial diarrhea and pseudomem-
branous colitis. Disease is mainly occurred in children 
who have been treated with long term antibiotics (Brown 
et al. 2015; Min Cho et al. 2012).
Changes in the epidemiology of C. difficile infections in 
the pediatric population is a serious concern. However, 
benign neonatal colonization with toxigenic C. difficile 
is a well-documented phenomenon but recent studies 
have suggested an increased incidence of C. difficile asso-
ciated diarrhea (CDAD) in children (Cohen et  al. 2006; 
Gleizes et  al. 2006). Previous investigation which was 
conducted on 22 hospitals in the United States reported 
an increased prevalence of CDAD in children (increased 
by 53  % from 2001 to 2006, with 26  % of patients with 
CDAD ≤1 year of age) (Cohen et al. 2006).
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Polymerase chain reaction (PCR)-based ribotyping 
of C. difficile in clinical samples is a good approach to 
identify the novel aspects in the epidemiology of diar-
rhea caused by this bacterium in children (Arvand et al. 
2009; Krutova et al. 2014). High prevalence of C. difficile 
ribotype 027 (RT027) in the clinical samples of pediatric 
patients have been reported in various studies (Arvand 
et  al. 2009; Krutova et  al. 2014; Oleastro et  al. 2014). 
Diarrheal disease caused by this ribotype of the C. dif-
ficile is more severe, with higher rates of morbidity and 
mortality and more virulent (Arvand et al. 2009; Krutova 
et al. 2014; Oleastro et al. 2014).
According to the high potential of C. difficile in causing 
infection, diarrhea and various complications in pediat-
rics, typing of this bacterium is essential to understand 
the exact epidemiology of outbreaks, identify any pos-
sible incidence of cross infection and to set up surveil-
lance programs to monitor virulent strain emergence 
and hospital reservoirs. However, few studies have been 
addressed in this field in Iran. Therefore, the present 
study was carried out in order to study the prevalence of 
C. difficile and its ribotypes in Iranian pediatric patients 
suffered from nosocomial diarrhea.
Results and discussion
Between zero to three antibiotics were used by patients 
with average 1.42 ± 0.68. Four patients did not take any 
antibiotic. Fifty-seven patients received one, thirty-two 
received two and seven received three types of antibiot-
ics. There were no antibiotic usage in the control group. 
Gentamycin, ceftriaxone, ampicillin, erythromycin, clin-
damycin and vancomycin were used in the pediatric 
patients of this study. The treatment periods by antibiot-
ics were different according to the type of infection. The 
average age of patients was 11.8  ±  15.3  months (range 
6–60 months), and 47 % were female. The average weight 
of patients was 9 ± 2.7 kg. Frequency of C. defficile based 
on each sex and age groups is shown in Table  1. Chi 
Square test didn’t show any significant difference for the 
distribution of C. defficile based on sex and age group of 
children. The most commonly used antibiotic agent was 
ceftriaxone (93  %). There were no significant relation 
between positive results with antibiotic treatment.
Electrophoresis of PCR products revealed 5–6 frag-
ments with 260–600 bp(s) length which showed the dis-
tribution of C. difficile ribotypes. From 100 examined 
samples, 52 (52  %) were positive for C. difficile. Total 
prevalence of C. difficile in girls and boys patients were 
48.9 and 54.7  %, respectively. Thirteen to twenty-four 
month age children had the highest prevalence of C. dif-
ficile. Of 130 fecal samples of healthy children, 6 samples 
(4.61 %), were positive for C. difficile. Boys had the higher 
prevalence of C. difficile than girls. Older than 24 months 
healthy children had the highest prevalence of C. difficile 
(15.6  %). There were statistically significant differences 
(p  <  0.05) for the prevalence of the C. difficile between 
healthy and sick groups. The most commonly detected 
ribotypes in the C. difficile isolates of hospitalized chil-
dren were RT027 (11.52  %), RT01 (9.61  %) and RT013 
(7.68 %) (Table 2). Totally, the ribotypes of the 13.44 % of 
C. difficile isolates of hospitalized children and all of the 
healthy children were not recognized.
C. difficile was the most common agent observed in 
52 % of episodes associated with nosocomial diarrhea in 
this pediatric population. The prevalence of C. difficile 
nosocomial diarrhea was varied in different studies, but 
there is limit studies in this field in Iran. Sadeghifard et al. 
(2010) were analyzed a total of 942 stool samples from 
Iranian patients with nosocomial diarrhea. They showed 
that 57 samples (6.1 %) were positive for toxigenic C. dif-
ficile (Sadeghifard et  al. 2010). One possible difference 
between our results and the results of Sadeghifard et al. 
Table 1 Prevalence of C. defficile based on sex and age groups
Groups of children Variable Group Positive Negative Total P value
Number Percent Number Percent Number Percent
Patients Sex Girl 23 48.9 24 51.1 47 100 0.564
Boy 29 54.7 24 45.3 53 100
Age 6–12 months 30 50 30 50 60 100 0.814
13–24 months 16 57.1 12 42.9 28 100
>24 months 6 50 6 50 12 100
Healthy Sex Girl 2 3.3 58 96.6 60 100 0.225
Boy 4 5.71 66 94.2 70 100
Age 6–12 months – – 58 100 58 100
13–24 months 1 2.5 39 97.5 40 100 0.198
>24 months 5 15.6 27 84.3 32 100 0.312
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(2010) was the fact that they found significant differences 
(p  <  0.05) between the rate of isolated toxigenic C. dif-
ficile and age of patients (Sadeghifard et al. 2010). Miller 
et  al. (2002) assessed the healthcare burden, morbidity, 
and mortality of nosocomial C. difficile-associated diar-
rhea (N-CDAD) in Canadian hospitals. They found that 
371 out of 2062 tested samples (18 %) were positive for 
C. difficile and 269 strains of total 371 positive isolates 
(13  %) met the case definition for nosocomial CDAD 
(Miller et al. 2002). In the survey which was conducted by 
Langley et al. (2002), C. difficile (39 of 122; 32 %) was one 
of the most common pathogens in nosocomial diarrhea 
episodes (Langley et  al. 2002) which was similar to our 
findings. In a study carried out by Gursoy et  al. (2007), 
the total prevalence of C. difficile was 27.7  % and the 
most commonly used antibiotic was clindamycin (Gursoy 
et al. 2007).
Direct detection of C. difficile toxin genes in stool sam-
ples by real-time PCR has a sensitivity superior than 
stool culture EIAs and performance comparable to that 
of real-time PCR assay of cultured isolates. Luna et  al. 
(2011) found that the sensitivities of stool real-time PCR 
and stool EIA were 95 and 35 %, respectively, with a spec-
ificity of 100 % for both methods (Luna et al. 2011).
In our study, majority of patients with C. difficile infec-
tions received antibiotics. One of the most frequent com-
plications of antibiotic therapy is diarrheal syndrome, 
which may be related both to the direct toxic effects of 
antibiotics on the gastrointestinal tract, and the activa-
tion of conditionally pathogenic intestinal flora. There-
fore, particular attention should perform on the problem 
of C. difficile infections, which may be the consequence 
of the development of pseudomembranous colitis in both 
children and adults (Zakharova et al. 2011).
Antimicrobial agents are the most frequently pre-
scribed medicines in children because of acute infectious 
diarrhea. The previous study which was conducted on 
the pediatric patients of same hospital represented that 
the total prescription of antibiotics in an irregular and 
inappropriate manner was 37 % (Khoshdel and Panahan-
deh 2012). Therefore, it is not surprising that the preva-
lence of C. difficile in the pediatric patients of our study 
was 52 %. Types of antibiotics used for treatment of cases 
of diarrhea can influence on the prevalence of C. difficile. 
It is because of the medical practitioners do not use inex-
pensive and easy assays like the disk diffusion method for 
antibiotic prescription. In fact, the experience of medi-
cal practitioners in the treatment of previous cases of 
diseases, is their main reason for antibiotic prescription. 
It is clear that the previous experiences of practitioners 
are not sufficient for treatment of the novel cases of dis-
eases like diarrhea. Therefore, prescription of antibiotics 
in a highly irregular manner and without accordance to 
the results of disk diffusion method, caused occurrence 
of antibiotic resistance in bacteria like C. difficile. There-
fore, presence of the resistant strains of this bacterium 
will increase. Low prevalence of this bacterium in healthy 
children which didn’t receive any antibiotics has indi-
rectly confirmed the relationship between antibiotic pre-
scription and occurrence of C. difficile infections.
Another part of our investigation has focused on the 
determination of ribotypes of C. difficle. Result showed 
that the most commonly detected ribotype in the C. diffi-
cile isolates of our investigation was RT027. Prior to 2003 
year, only a handful of these strains were isolated in the 
United Kingdom, whereas currently most typed isolates 
are RT027. This is also mirrored in Canada, where RT027 
strains were undetected in 2000, but reached 75.2 % of all 
PCR-ribotype strains in 2003 (MacCannell et  al. 2006). 
Kuijper et al. (2008) reported that the RT027 of the C. dif-
ficile was the most commonly detected ribotypes in the 
cases of severe complicated diarrhea. High prevalence 
of the RT027 strains of C. difficile have been reported 
in majority of European countries such as Germany, 
France, Belgium, Ireland, Finland, Poland, Spain, Hun-
gary, the Netherlands, Switzerland, Luxembourg and also 
the United Kingdom (Kuijper et al. 2008). Oleastro et al. 
Table 2 Distribution of ribotypes of C. difficile in the stool 
specimens of hospitalized and healthy pediatric of Iran
a Unknown ribotype




Number Percent (%) Number Percent (%)
R1 5 9.61 – –
R7 2 3.84 – –
R8 2 3.84 – –
R12 3 5.76 – –
R13 4 7.68 – –
R15 3 5.76 – –
R18 3 5.76 – –
R27 6 11.52 – –
R28 2 3.84 – –
R29 3 5.76 – –
R31 3 5.76 – –
R32 1 1.92 – –
R81 1 1.92 – –
R82 1 1.92 – –
R83 2 3.84 – –
R86 1 1.92 – –
R87 2 3.84 – –
R88 1 1.92 – –
a 7 13.44 6 100
Total 52 100 6 100
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(2014) reported that 72.72 % of the C. difficile isolates of 




This research project has been approved by the ethical 
committee of Shahrekord University of Medical Sciences, 
Iran. Informed consent was obtained from pediatrics or 
their parents.
Samples collection and bacterial isolation
This cross-sectional study was conducted from Decem-
ber 2013 to May 2014. The studied population comprised 
all patients, aged 6–60 months, who had been hospital-
ized in the pediatric ward of Hospitals because of dis-
eases other than diarrhea such as urinary tract infection, 
bacterial pneumonia, acute respiratory illness and skin 
infections. Fecal specimens were collected from 100 chil-
dren with clinical signs of nosocomial diarrhea admitted 
in the hospitals and health centers of south west of Iran. 
Nosocomial diarrhea was defined as diarrhea occurring 
more than 72 h after admission to hospital for non-diar-
rheal causes. The fecal samples were transported daily 
to the Cellular and Molecular Research Center, Shahre-
kord University of Medical Sciences in refrigerated boxes 
using the Cary-Blair transport (Para-Pak™ C&S trans-
port media; Meridian Diagnostics, Cincinnati, OH, USA) 
transitional media. The fecal samples of 130 healthy 
children with similar criteria (male and female, aged 
6–60 months) were also collected for the control group.
Five gram of each sample was transferred to 20 mL of 
C. difficile broth (CDB; Oxoid SR0048) containing 40 g/l 
proteose peptone, 5.0 g/l disodium hydrogen phosphate, 
0.1  g/l magnesium sulphate, 2.0  g/l sodium chloride, 
6.0 g/l fructose and 1.0 g/l sodium taurocholate supple-
ment with C. difficile selective supplement (Oxoid, UK, 
Code: SR0173) and 5  % (v/v) defibrinated sheep blood. 
After incubation at 37 °C for 2 days under anaerobic con-
ditions, 2 mL of the enrichment broth was added to 2 mL 
of 96 % ethanol in a centrifuge tube and homogenized for 
50 min on a shaker at room temperature. After centrifu-
gation (3800×g for 10 min), a loopful of the sediment was 
streaked onto cycloserine cefoxitin fructose agar (CCFA) 
containing sodium taurocholate. All plates were incu-
bated in an anaerobic chamber (Don Whitley Scientific 
Ltd., Shipley West Yorkshire, UK) at 37 °C for 48 h. Col-
onies of C. difficile were identified on the basis of their 
characteristic colony morphology (yellow, ground glass 
appearance), Gram staining, odour (horse dung smell), 
their chartreuse fluorescence under long-wave UV light 
(~360  nm) and l-proline aminopeptidase test (Harvey 
et al. 2011).
Ribotyping of C. difficile
Genomic DNA was extracted from typical colonies of C. 
difficile using genomic DNA extraction Kit (Fermentase, 
Germany) according to the manufacturer’s recommen-
dation. The isolated DNA was quantified by spectro-
photometric measurement at a wave length of 260  nm 
according to the method described by Sambrook and 
Russell (2001). The extracted DNA of each specimen 
was kept frozen at −20 °C until used. Colonies of C. dif-
ficile were approved another one using the real-time PCR 
method described by Bélanger et al. (2003).
PCR ribotyping
Ribotyping was done in the Biotechnology Research 
Center of the Islamic Azad University of Shahrekord 
Branch, Iran. PCR technique was used to study the dis-
tribution of ribotypes of C. difficile. The oligonucleotide 
primers p3-F: 5′-CTGGGGTGAAGTCGTAACAAGG-3′ 
(position 1445–1466 of the 16S rRNA gene) and p5-R: 
5′-GCGCCCTTTGTAGCTTGACC-3′ (position 20–1 
of the 23S rRNA gene) described by Stubbs et al. (1999) 
were used for gene amplification. C. difficile 027/NAP1/
BI strain was used as a positive control. A negative-DNA 
control was performed by adding 1 μL of sterile ultrapure 
deionized water. For investigation of ribotypes of C. dif-
ficile the specimens were amplified in a Gradient Palm 
Cycler (Corbett Research, Australia) and PCR was per-
formed in a total volume of 25 μL including 0.5 ml tubes 
containing 1 μg of genomic DNA, 1 μM of each primer, 
2 mM MgCl2, 200 Μm dNTP, 2.5 μL of 10× PCR buffer 
and 1 unit of Taq DNA polymerase (Fermentas, Ger-
many). PCR cycles consisted of an initial denaturation 
step (95 °C for 5 min) followed by 30 amplification cycles 
(denaturation at 94  °C for 1 min, annealing at 62  °C for 
1  min, and elongation at 72  °C for 1  min) with a final 
elongation at 72 °C for 5 min and amplified samples were 
held at 4 °C.
Analysis of PCR products
The amplified products were detected in 1  % aga-
rose gel electrophoresis. The electrode buffer was 
TBE [Tris-base 10.8 g 89 mM, Boric acid 5.5 g 2 mM, 
EDTA (pH 8.0) 4 ml of 0.5 M EDTA (pH 8.0), combine 
all components in sufficient H2O and stir to dissolve]. 
Aliquots of 10 µL of PCR products were applied to the 
gel. Constant voltage of 80  V for 30  min was used for 
products separation. The DNA fragment size was com-
pared with a standard molecular weight (100 bp DNA 
ladder of Fermentas, Germany). After electrophoresis, 
the amplicons were visualized with ultraviolet light 
after ethidium bromide (5 μg mL−1) staining and pho-
tographs were obtained in UVIdoc gel documentation 
systems (UK).
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Ribotyping patterns
Comparison of PCR ribotyping patterns was performed 
visually. All isolates were typed using the PCR ribotyp-
ing method described by Bidet et al. (1999) and Gel Com-
pare software. Strains with ribotype patterns that differed 
by at least one band were assigned to different types. 
Ribotype group was designated by upper and lower-case 
letters combined with a number.
Statistical analysis
Analysis of data and investigation of ribotypes of C. dif-
ficile were performed using the SPSS (version 11.5) and 
Gel Compar software.
Conclusion
The present study showed a low frequency of noso-
comial infection due to C. difficile and especially it’s 
RT027. Our work emphasizes the importance of noso-
comial infections in pediatric wards which is important 
as its considerable costs of hospitalization and treat-
ment. A continued ribotype surveillance of C. difficile 
is necessary to monitor changes in the prevalence of 
strains, to identify the emergence of new strains over 
time that could affect future vaccine strategies, and to 
identify any regional differences of ribotype preva-
lence. Clinician should pay more attention in prescrip-
tion of antibiotics in the cases of diarrhea especially in 
children.
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